Syngene International Adjusts Evaluation Amid Mixed Technical Indicators and Growth Challenges
Syngene International has recently adjusted its evaluation, reflecting changes in the technical landscape. While recent financial performance showed growth in profit and net sales, the company faces challenges with long-term growth metrics and has underperformed against broader market indices over the past year.
Syngene International, a prominent player in the healthcare services sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, moving from a mildly bearish stance to a sideways trend. The technical indicators present a mixed picture. The MACD shows a mildly bullish signal on a weekly basis, while the monthly perspective leans bearish. The Relative Strength Index (RSI) indicates no signal on a weekly basis but is bullish monthly. Bollinger Bands suggest a bullish outlook weekly, contrasting with a mildly bearish monthly trend. Daily moving averages are mildly bearish, while the KST presents a mildly bullish weekly view but is bearish monthly. The Dow Theory indicates no trend on a weekly basis, with a mildly bullish monthly outlook. On-Balance Volume (OBV) shows a mildly bullish trend for both weekly and monthly periods.
Despite the recent positive financial performance in Q4 FY24-25, including a notable growth in profit after tax and net sales, the company faces challenges with long-term growth metrics. The stock has generated a return of -10.91% over the past year, underperforming against broader market indices.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
